USEFULNESS OF TC-99M N,N'-ETHYLENE-1-DICYSTEINE COMPLEX FOR DYNAMIC KIDNEY INVESTIGATIONS

被引:24
作者
SURMA, MJ
WIEWIORA, J
LINIECKI, J
机构
[1] Department of Nuclear Medicine, Medical University of Łódź, Łódź, PL, 92-216
关键词
D O I
10.1097/00006231-199408000-00007
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
To assess the usefulness of the Tc-99m-ethylene-1-dicysteine (Tc-99m-EC) complex for examination of kidney function, dynamic kidney scintigraphy with Tc-99m--EC and clearance determinations were performed. During renoscintigraphy the kidney images were of superb quality, with overlying organs (liver, spleen) not visualized. Renograms showed typical shapes, their T(max) and T1/2 values being unsignificantly different from the values obtained with other radiopharmaceuticals used in renoscintigraphy (mercaptoacetyl triglycine, hippuran). Very strict correlations were found between values of Tc-99m-EC and I-131-iodohippurate (OIH) clearances (r=0.91) and excretion rate constants (r=0.92) for both radiopharmaceuticals. The correlation enabled the formulation of an equation by which effective renal plasma flow (ERPF) could be established from Tc-99m-EC clearance: ERPF(OIH) = 1.245 X CI(EC) + 51.52. On the basis of this equation a lower boundary of the normal Tc-99m-EC clearance was established; it amounts to 300 ml min-1 1.73 m-2.
引用
收藏
页码:628 / 635
页数:8
相关论文
共 22 条
[1]   COMPARISON OF TC-99M-MERCAPTOACETYLTRIGLYCINE AND I-131 ORTHOIODOHIPPURATE IN DETERMINATION OF EFFECTIVE RENAL PLASMA-FLOW (ERPF) [J].
ABDELDAYEM, HM ;
SADEK, S ;
ALBAHAR, R ;
SABHA, M ;
ELSAYED, M .
NUCLEAR MEDICINE COMMUNICATIONS, 1989, 10 (02) :99-107
[2]   CLINICAL-EXPERIENCE WITH TC-99M-MAG3, MERCAPTOACETYLTRIGLYCINE, AND A COMPARISON WITH TC-99M-DTPA [J].
ALNAHHAS, AA ;
JAFRI, RA ;
BRITTON, KE ;
SOLANKI, K ;
BOMANJI, J ;
MATHER, S ;
CARROLL, MA ;
ALJANABI, M ;
FRUSCIANTE, V ;
AJDINOWIC, B ;
FIORE, F ;
DEMENA, S ;
NIMMON, CC .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (9-10) :453-462
[3]  
BUBECK B, 1986, NUC COMPACT, V17, P135
[4]  
ESHIMA D, 1987, J NUCL MED, V28, P1180
[5]  
FRITZBERG AR, 1986, J NUCL MED, V27, P111
[6]  
JAMAR F, 1993, EUR J NUCL MED, V20, P831
[7]  
KABASAKAL L, 1993, EUR J NUCL MED, V20, P831
[8]  
NAEGELWOEHRLE B, 1988, NUC COMPACT, V19, P85
[9]  
OGINSKI M, 1983, NUKLEARMED, V22, P136
[10]  
PIXBERG HU, 1977, KLINISCHER STELLENWE, P31